Vera Therapeutics Newsroom

Vera Therapeutics (VERA) Gets a Buy From J.P. Morgan

TipRanksNov 21 20:08

Wells Fargo Initiates Vera Therapeutics(VERA.US) With Buy Rating, Announces Target Price $70

Futu NewsNov 21 19:32

Vera Therapeutics Price Target Raised to $38.00/Share From $30.00 by Wedbush

Dow JonesNov 8 23:22

Vera Therapeutics Is Maintained at Neutral by Wedbush

Dow JonesNov 8 23:22

Vera Therapeutics Analyst Ratings

BenzingaNov 8 23:11

Evercore Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $75

Futu NewsNov 8 22:38

TD Cowen Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $60

Futu NewsNov 8 21:32

TD Cowen Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $60

Futu NewsNov 8 12:32

LifeSci Capital Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $70

Futu NewsNov 8 03:33

Vera Therapeutics: Strong Buy Rating Backed by Financial Stability and Promising Atacicept Data

TipRanksNov 8 02:53

Vera Therapeutics Analyst Ratings

BenzingaNov 6 00:08

J.P. Morgan Maintains Vera Therapeutics(VERA.US) With Buy Rating, Raises Target Price to $75

Futu NewsNov 5 20:31

LifeSci Capital Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $70

Futu NewsOct 29 04:32

Vera Therapeutics Analyst Ratings

BenzingaOct 29 00:38

Guggenheim Maintains Vera Therapeutics(VERA.US) With Buy Rating, Raises Target Price to $64

Futu NewsOct 28 22:31

Evercore Maintains Vera Therapeutics(VERA.US) With Buy Rating, Raises Target Price to $75

Futu NewsOct 28 22:31

A Quick Look at Today's Ratings for Vera Therapeutics(VERA.US), With a Forecast Between $60 to $75

Futu NewsOct 28 21:03

Promising Clinical Data and Strong Financials Justify Buy Rating for Vera Therapeutics Amid Atacicept's Potential in IgAN

TipRanksOct 28 03:09

Evercore Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $50

Futu NewsOct 23 20:31

LifeSci Capital Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $70

Futu NewsOct 23 03:32